Microtumor growth initiates angiogenic sprouting with simultaneous expression of VEGF, VEGF receptor-2, and angiopoietin-2
Open accessThe DOI matches its OpenAlex record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
Tumors have been thought to initiate as avascular aggregates of malignant cells that only later induce vascularization. Recently, this classic concept of tumor angiogenesis has been challenged by the suggestion that tumor cells grow by co-opting preexisting host vessels and thus initiate as well-vascularized tumors without triggering angiogenesis. To discriminate between these two mechanisms, we have used intravital epifluorescence microscopy and multi-photon laser scanning confocal microscopy to visualize C6 microglioma vascularization and tumor cell behavior. To address the mechanisms underlying tumor initiation, we assessed the expression of VEGF, VEGF receptor-2 (VEGFR-2), and angiopoietin-2 (Ang-2), as well as endothelial cell proliferation. We show that multicellular aggregates (<< 1 mm(3)) initiate vascular growth by angiogenic sprouting via the simultaneous expression of VEGFR-2 and Ang-2 by host and tumor endothelium. Host blood vessels are not co-opted by tumor cells but rather are used as trails for tumor cell invasion of the host tissue. Our data further suggest that the established microvasculature of growing tumors is characterized by a continuous vascular remodeling, putatively mediated by the expression of VEGF and Ang-2. The results of this study suggest a new concept of vascular tumor initiation that may have important implications for the clinical application of antiangiogenic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tumor angiogenesis: therapeutic implications
Sherwood, L. M., Parris, E. E., & Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197111182852108 · Cited by 10,187 · cited 3×
“Introduction The paradigm that primary tumors and metastases initiate avascularly and only later induce their vascularization has become widely accepted (1, 2).”
Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis
Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699 · cited 1×
“the host microvasculature initiate by co-opting vessels (6).”
Angiopoietin-2, a Natural Antagonist for Tie2 That Disrupts in vivo Angiogenesis
Maisonpierre, P. C., Suri, C., Jones, P. F., Bartunkova, S., Wiegand, S. J., Radziejewski, C., Compton, D., McClain, J., Aldrich, T. H., Papadopoulos, N., et al. (1997) · Science · doi:10.1126/science.277.5322.55 · Cited by 3,570
Transplacental Carcinogenesis by Stilbestrol
Folkman, J. (1971) · New England Journal of Medicine · doi:10.1056/nejm197108122850711 · Cited by 2,640
Plate, K. H., Breier, G., Weich, H. A., & Risau, W. (1992) · Nature · doi:10.1038/359845a0 · Cited by 2,275 · cited 2×
“With respect to tumor angiogenesis, it is generally assumed that the rapid proliferation of tumor cells, in combination with the reduced functionality of tumor blood vessels, causes local tissue hypoxia in tumors, leading to the upregulation of VEGF expression, which in turn stimulates the compensatory growth of blood…”
Self-citationVessel Cooption, Regression, and Growth in Tumors Mediated by Angiopoietins and VEGF
Holash, J., Maisonpierre, P. C., Compton, D., Boland, P., Alexander, C. R., Zagzag, D., Yancopoulos, G. D., & Wiegand, S. J. (1999) · Science · doi:10.1126/science.284.5422.1994 · Cited by 2,195 · cited 5×
“To test this hypothesis, tumor cells of the same line as reported previously (4, 5), i.”
InfluentialMillauer, B., Wizigmann-Voos, S., Schnürch, H., Martinez, R., Møller, N. P. H., Risau, W., & Ullrich, A. (1993) · Cell · doi:10.1016/0092-8674(93)90573-9 · Cited by 1,927 · cited 3×
“The murine VEGFR-2 (Flk-1) probe spans the extracellular portion of the receptor (14).”
Cell and environment interactions in tumor microregions: the multicell spheroid model.
Sutherland, R. M. (1988) · Science · doi:10.1126/science.2451290 · Cited by 1,803 · cited 2×
“The advantage of using multicellular spheroids is twofold: first, in contrast to tumor cell suspensions, multicellular tumor spheroids exhibit structural and functional differentiation similar to that of solid tumors (29).”
Helmlinger, G., Yuan, F., Dellian, M., & Jain, R. K. (1997) · Nature Medicine · doi:10.1038/nm0297-177 · Cited by 1,628 · cited 1×
“Both implantation sites have a high vascular density (308 ± 27 cm–1 and 294 ± 5 cm–1) and low intercapillary distance (24 ± 8 μm and 34 ± 4 μm), guaranteeing that the implanted tumor cells were located well within the 100-μm diffusion limit for oxygen (24).”
Cited by
Tumorigenesis and the angiogenic switch
Bergers, G., & Benjamin, L. E. (2003) · Nature reviews. Cancer · doi:10.1038/nrc1093 · Cited by 3,559
“They instead grow along blood vessels, without a tumour capsule, eliciting an invasive character, and can enlarge as much as some angiogenic tumour”
Friends or foes — bipolar effects of the tumour stroma in cancer
Mueller, M. M., & Fusenig, N. E. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1477 · Cited by 1,765
Vinci, M., Gowan, S., Boxall, F., Patterson, L., Zimmermann, M., Court, W., Lomas, C., Mendiola, M., Hardisson, D., & Eccles, S. A. (2012) · BMC Biology · doi:10.1186/1741-7007-10-29 · Cited by 1,024
“We utilized a tumor spheroid-based migration assay that resembles tumor cell dissemination from a solid microtumor or micrometastasis in terms of engagement of host stromal matrix proteins with characteristics that differ from isolated cells [39-41].”
MethodFiedler, U., Reiss, Y., Scharpfenecker, M., Grunow, V., Koidl, S., Thurston, G., Gale, N. W., Witzenrath, M., Rosseau, S., Suttorp, N., et al. (2006) · Nature Medicine · doi:10.1038/nm1351 · Cited by 933
“We assessed vessel diameters using a computer-assisted image analysis syste”
MethodSelf-citationErber, R., Thurnher, A., D. Katsen, A., Groth, G., Kerger, H., Hammes, H., D. Menger, M., Ullrich, A., & Vajkoczy, P. (2004) · The FASEB Journal · doi:10.1096/fj.03-0271fje · Cited by 610
Self-citationRong, Y., Durden, D. L., Van Meir, E. G., & Brat, D. J. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-200606000-00001 · Cited by 567
Nonlinear modelling of cancer: bridging the gap between cells and tumours
Lowengrub, J. S., Frieboes, H. B., Jin, F., Chuang, Y.-L., Li, X., Macklin, P., Wise, S. M., & Cristini, V (2010) · Nonlinearity · doi:10.1088/0951-7715/23/1/r01 · Cited by 553
A critical analysis of current in vitro and in vivo angiogenesis assays
Staton, C. A., Reed, M. W. R., & Brown, N. J. (2009) · International Journal of Experimental Pathology · doi:10.1111/j.1365-2613.2008.00633.x · Cited by 469
Vasculogenesis and Angiogenesis
Patan, S. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_1 · Cited by 430
The role of the Angiopoietins in vascular morphogenesis
Thomas, M., & Augustin, H. G. (2009) · Angiogenesis · doi:10.1007/s10456-009-9147-3 · Cited by 405
Darland, D. C., Massingham, L. J., Smith, S. R., Piek, E., Saint-Geniez, M., & D'Amore, P. A. (2003) · Developmental Biology · doi:10.1016/j.ydbio.2003.08.015 · Cited by 383
Brat, D. J., & Van Meir, E. G. (2004) · Laboratory Investigation · doi:10.1038/labinvest.3700070 · Cited by 330
Targeting the tumor stroma for cancer therapy
Xu, M., Zhang, T., Xia, R., Wei, Y., & Wei, X. (2022) · Molecular Cancer · doi:10.1186/s12943-022-01670-1 · Cited by 319
Donnem, T., Hu, J., Ferguson, M., Adighibe, O., Snell, C., Harris, A. L., Gatter, K. C., & Pezzella, F. (2013) · Cancer Medicine · doi:10.1002/cam4.105 · Cited by 275
Elvert, G., Kappel, A., Heidenreich, R., Englmeier, U., Lanz, S., Acker, T., Rauter, M., Plate, K., Sieweke, M., Breier, G., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211298200 · Cited by 271
Self-citationCannabinoids Inhibit the Vascular Endothelial Growth Factor Pathway in Gliomas
Blázquez, C., González-Feria, L., Álvarez, L., Haro, A., Casanova, M. L., & Guzmán, M. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3927 · Cited by 255
Complementary Actions of Inhibitors of Angiopoietin-2 and VEGF on Tumor Angiogenesis and Growth
Hashizume, H., Falcón, B. L., Kuroda, T., Baluk, P., Coxon, A., Yu, D., Bready, J. V., Oliner, J. D., & McDonald, D. M. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-1977 · Cited by 251
“Angiogenesis inhibitors can reduce the number of tumor vessels by inhibition of endothelial sprouting and new vessel growth (35, 38) or by causing regression of existing vessels (3, 39).”
BackgroundImpact of pore size on the vascularization and osseointegration of ceramic bone substitutes in vivo
Klenke, F. M., Liu, Y., Yuan, H., Hunziker, E. B., Siebenrock, K. A., & Hofstetter, W. (2008) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.31559 · Cited by 227
“The method has been used to investigate the cerebral microcirculation in rats and the angiogenesis of malignant cranial tumours in mice.(14-19) Although the cranium has been used as an implantation site for bone substitutes in rodents,(20-22) intravital microscopy has not been applied to investigate the angiogenesis a…”
MethodXue, Y., Cao, R., Nilsson, D., Chen, S., Westergren, R., Hedlund, E.-M., Martijn, C., Rondahl, L., Krauli, P., Walum, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802486105 · Cited by 112
Vascular microenvironment in gliomas
Vajkoczy, P., & Menger, M. D. (2004) · Cancer Treatment and Research · doi:10.1007/978-1-4419-8871-3_15 · Cited by 62
Self-citation
Metadata
- Authors
- Vajkoczy, P., Farhadi, M. R., Gaumann, A. K. A., Heidenreich, R., Erber, R., Wunder, A., Tonn, J. C., Menger, M. D., & Breier, G.
- Venue
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Published
- 2002-03-15
- Volume
- 109
- Issue
- 6
- Pages
- 777-785
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W1986154258
- Cited by
- 219
- References
- 41
- FWCI
- 6.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.